logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

BamlanivimabDiffuse C4d staining of peritubular capillaries following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1897卷 / 1期
关键词:
D O I:
10.1007/s40278-022-11323-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:86 / 86
相关论文
共 50 条
  • [41] GlibenclamideHypoglycaemia following an off-label use : case report
    Reactions Weekly, 2021, 1866 (1) : 190 - 190
  • [42] SintilimabFasciitis following off-label use: case report
    Reactions Weekly, 2021, 1884 (1) : 391 - 391
  • [43] HydroxychloroquineEosinophilia following off-label use: case report
    Reactions Weekly, 2021, 1867 (1) : 204 - 204
  • [44] DexamethasoneMucormycosis following off-label use: case report
    Reactions Weekly, 2023, 1956 (1) : 181 - 181
  • [45] HydroxychloroquineHaemolysis following off-label use: case report
    Reactions Weekly, 2021, 1836 (1) : 376 - 376
  • [46] IvabradinePhosphene following off-label use: case report
    Reactions Weekly, 2019, 1769 (1) : 267 - 267
  • [47] CeftriaxoneCholelithiasis following off-label use: case report
    Reactions Weekly, 2021, 1880 (1) : 118 - 118
  • [48] SpironolactoneDysmenorrhoea following off-label use : case report
    Reactions Weekly, 2024, 2018 (1) : 430 - 430
  • [49] AmantadineConstipation following off-label use: case report
    Reactions Weekly, 2019, 1760 (1) : 20 - 20
  • [50] MethylprednisoloneOsteoporosis following off-label use: case report
    Reactions Weekly, 2025, 2053 (1) : 203 - 203
← 12345 →